{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:36Z","timestamp":1790078616726,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00330-017-4736-9","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T09:59:15Z","timestamp":1485165555000},"page":"3662-3668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting"],"prefix":"10.1007","volume":"27","author":[{"given":"John C.","family":"Waterton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilien","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Nordenmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenael","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Buonaccorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey J. M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Peterfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"4736_CR1","first-page":"1385","volume":"6","author":"M \u00d8stergaard","year":"2003","unstructured":"\u00d8stergaard M, Peterfy C, Conaghan P et al (2003) OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 6:1385\u20131386","journal-title":"J Rheumatol"},{"key":"4736_CR2","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/art.21493","volume":"52","author":"EA Haavardsholm","year":"2005","unstructured":"Haavardsholm EA, \u00d8stergaard M, Ejbjerg BJ et al (2005) Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting. Arthritis Rheum 52:3860\u20133867","journal-title":"Arthritis Rheum"},{"key":"4736_CR3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/annrheumdis-2012-202696","volume":"72","author":"C Peterfy","year":"2013","unstructured":"Peterfy C, \u00d8stergaard M, Conaghan PG (2013) MRI comes of age in RA clinical trials. Ann Rheum Dis 72:794\u2013796","journal-title":"Ann Rheum Dis"},{"key":"4736_CR4","doi-asserted-by":"publisher","unstructured":"Kessler LG, Barnhart HX, Buckler AJ, et al. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Stat Methods Med Res Published online first 11 June 2014 doi:\n10.1177\/0962280214537333","DOI":"10.1177\/0962280214537333"},{"key":"4736_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T\n                    \n                        1\n                     weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223\u2013232","journal-title":"J Magn Reson Imaging"},{"key":"4736_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrclinonc.2012.2","volume":"9","author":"JPB O'Connor","year":"2012","unstructured":"O'Connor JPB, Jackson A, Parker GJM, Roberts C, Jayson GC (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Onc 9:167\u2013177","journal-title":"Nat Rev Clin Onc"},{"key":"4736_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/kem250","volume":"47","author":"RJ Hodgson","year":"2008","unstructured":"Hodgson RJ, O'Connor P, Moots R (2008) MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology (Oxford) 47:13\u201321","journal-title":"Rheumatology (Oxford)"},{"key":"4736_CR8","doi-asserted-by":"crossref","unstructured":"Beals C, Baumgartner R, Peterfy C et al (2013) Treatment effects measured by dynamic contrast enhanced MRI and RAMRIS for rheumatoid arthritis. Ann Rheum Dis 72:Suppl 3 A748","DOI":"10.1136\/annrheumdis-2013-eular.2216"},{"key":"4736_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/art.10084","volume":"46","author":"RJ Reece","year":"2002","unstructured":"Reece RJ, Kraan MC, Radjenovic A et al (2002) Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 46:366\u2013372","journal-title":"Arthritis Rheum"},{"key":"4736_CR10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/annrheumdis-2014-205361","volume":"74","author":"PC Taylor","year":"2015","unstructured":"Taylor PC, Genovese MC, Greenwood M et al (2015) OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy. Ann Rheum Dis 74:2123\u20132129","journal-title":"Ann Rheum Dis"},{"key":"4736_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","volume":"63","author":"MC Genovese","year":"2011","unstructured":"Genovese MC, Kavanaugh A, Weinblatt ME et al (2011) An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents. Arthritis Rheum 63:337\u2013345","journal-title":"Arthritis Rheum"},{"key":"4736_CR12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0730-725X(93)90222-Y","volume":"11","author":"JC Waterton","year":"1993","unstructured":"Waterton JC, Rajanayagam V, Ross BD, Brown D, Whittemore A, Johnstone D (1993) Magnetic resonance methods for measurement of disease progression in rheumatoid arthritis. Magn Reson Imaging 11:1033\u20131038","journal-title":"Magn Reson Imaging"},{"key":"4736_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1039\/9781849737661-00333","volume-title":"New applications of NMR in drug discovery and development","author":"JC Waterton","year":"2013","unstructured":"Waterton JC (2013) Translational magnetic resonance imaging and spectroscopy: opportunities and challenges. In: Garrido L, Beckmann N (eds) New applications of NMR in drug discovery and development. RSC press, Cambridge, pp 333\u2013360"},{"key":"4736_CR14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00330-014-3470-9","volume":"25","author":"I Eshed","year":"2015","unstructured":"Eshed I, Krabbe S, \u00d8stergaard M et al (2015) Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI: a comparison with contrast-enhanced MRI. Eur Radiol 25:1059\u20131067","journal-title":"Eur Radiol"},{"key":"4736_CR15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00330-012-2446-x","volume":"22","author":"MO Leach","year":"2012","unstructured":"Leach MO, Morgan B, Tofts PS et al (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22:1451\u20131464","journal-title":"Eur Radiol"},{"key":"4736_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/3-540-26420-5_5","volume-title":"Dynamic contrast-enhanced magnetic resonance imaging in oncology","author":"DL Buckley","year":"2005","unstructured":"Buckley DL, Parker GJM (2005) Measuring contrast agent concentration in T\n                    \n                        1\n                    -weighted dynamic contrast-enhanced MRI. In: Jackson A, Buckley DL, Parker GJM (eds) Dynamic contrast-enhanced magnetic resonance imaging in oncology. Springer, Heidelberg, pp 69\u201379"},{"key":"4736_CR17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/kep343","volume":"49","author":"C Malattia","year":"2010","unstructured":"Malattia C, Damasio MB, Basso C et al (2010) Dynamic contrast-enhanced magnetic resonance imaging in the assessment of disease activity in patients with juvenile idiopathic arthritis. Rheumatol 49:178\u2013185","journal-title":"Rheumatol"},{"key":"4736_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mrm.21349","volume":"58","author":"RJ Hodgson","year":"2007","unstructured":"Hodgson RJ, Connolly S, Barnes T, Eyes B, Campbell RS, Moots R (2007) Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy. Magn Reson Med 58:482\u2013489","journal-title":"Magn Reson Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-4736-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T11:07:31Z","timestamp":1501844851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-4736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4736"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-4736-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]}}}